Cite
APA Citation
Shaulov, A., Ganzel, C., Benyamini, N., Barshay, Y., Goldschmidt, N., Lavie, D., Libster, D., Gural, A., Avni, B., & Gatt, M. E. (n.d.). progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. American journal of hematology, 92(2), 131–135. http://access.bl.uk/ark:/81055/vdc_100040554778.0x00002f